The AmpliVue™ Trichomonas Assay (Quidel) is a new FDA cleared rapid test for qualitative detection of Trichomonas vaginalis (TV) DNA in female vaginal specimens. The assay is based on BioHelix’s Helicase-Dependent Amplification (HDA) isothermal technology in conjunction with a disposable lateral-flow detection device, with a total turn-around time of approximately 45 minutes
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomonas vaginalis is the most common curable sexually transmitted infection (STI) worldwide. Alt...
Background: Trichomoniasis is the most common sexually transmitted disease. However, limited data ar...
BACKGROUND: Trichomonasvaginalis (TV) is a highly prevalent parasitic infection worldwide. It is ass...
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomonas vaginalis infection is estimated to be the most widely prevalent nonviral sexually trans...
Recent advances in tests for the sexually transmitted protozoan parasite Trichomonas vaginalis have ...
Trichomonas vaginalis (TV) rates in women are increasing and many are asymptomatic. Nucleic acid amp...
Background. Diagnosis of Trichomonas vaginalis (TV) infection is limited by imperfect testing method...
AbstractThis is an evaluation study of the Prestoplus Assay for T. vaginalis by comparing to the TIB...
Trichomoniasis is the most prevalent curable sexually transmitted disease (STD). It has been associa...
Trichomoniasis is the most prevalent curable sexually transmitted disease (STD). It has been associa...
Trichomoniasis caused by Trichomonas vaginalis is a common sexually transmitted disease. Its associa...
Trichomonas vaginalis infection is highly prevalent worldwide and is associated with poor birth outc...
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomonas vaginalis is the most common curable sexually transmitted infection (STI) worldwide. Alt...
Background: Trichomoniasis is the most common sexually transmitted disease. However, limited data ar...
BACKGROUND: Trichomonasvaginalis (TV) is a highly prevalent parasitic infection worldwide. It is ass...
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomonas vaginalis infection is estimated to be the most widely prevalent nonviral sexually trans...
Recent advances in tests for the sexually transmitted protozoan parasite Trichomonas vaginalis have ...
Trichomonas vaginalis (TV) rates in women are increasing and many are asymptomatic. Nucleic acid amp...
Background. Diagnosis of Trichomonas vaginalis (TV) infection is limited by imperfect testing method...
AbstractThis is an evaluation study of the Prestoplus Assay for T. vaginalis by comparing to the TIB...
Trichomoniasis is the most prevalent curable sexually transmitted disease (STD). It has been associa...
Trichomoniasis is the most prevalent curable sexually transmitted disease (STD). It has been associa...
Trichomoniasis caused by Trichomonas vaginalis is a common sexually transmitted disease. Its associa...
Trichomonas vaginalis infection is highly prevalent worldwide and is associated with poor birth outc...
Trichomoniasis is a common sexually transmitted disease associated with preterm birth, low birth wei...
Trichomonas vaginalis is the most common curable sexually transmitted infection (STI) worldwide. Alt...
Background: Trichomoniasis is the most common sexually transmitted disease. However, limited data ar...